Abstract
Most groups now obtain high cure rates in paediatric extracranial MGCTs, mostly using cisplatin-based chemotherapy [1–4]. In Britain, a carboplatin-based regimen (carboplatin, etoposide and bleomycin — JEB) is preferred because it is less oto- and nephrotoxic [5]. An analysis of the UKCCSG’s second study (GCII) aimed to define risk groups in order to refine therapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Haas RJ, Schmidt P, Göbel U, Harms D. Testicular germ cell tumors, an update. Results of the German Cooperative studies 1982–1997. Klin Pädiatr 1999;211:300–305
Göbel U, Schneider DT, Calaminus G et al. Multimodal treatment of malignant sacrococcygeal germ cell tumors: a prospective analysis of 66 patients of the German cooperative protocols MAKEI 83/86 and 89. J Clin Oncol 2001;19:1943–1950
Baranzelli MC, Kramer A, Bouffet E et al. Prognostic factors in children with localized malignant nonseminomatous germ cell tumors. J Clin Oncol 1999;17:1212–1218
Rescorla F, Billmire D, Stolar C et al. The effect of cisplatin dose an surgical resection in children with malignant germ cell tumors at the sacrococcygeal region: a Pediatric Intergroup Trial (POG 9049/CCG 8882). J Ped Surg 2001;36:12–17
Mann JR, Raafat F, Robinson K et al. The United Kingdom Children’s Cancer Study Group’s second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity: J Clin Oncol 2000;22:3809–3818
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag London Limited
About this paper
Cite this paper
Mann, J.R. et al. (2002). Risk Factors in Malignant Extracranial Germ Cell Tumours (MGCTs) of Childhood: Analysis of UKCCSG’s GCII Study. In: Harnden, P., Joffe, J.K., Jones, W.G. (eds) Germ Cell Tumours V. Springer, London. https://doi.org/10.1007/978-1-4471-3281-3_25
Download citation
DOI: https://doi.org/10.1007/978-1-4471-3281-3_25
Publisher Name: Springer, London
Print ISBN: 978-1-4471-3283-7
Online ISBN: 978-1-4471-3281-3
eBook Packages: Springer Book Archive